Small, Mid-size Biotechs Could See M&A Action in H2 - PwC

Seeking Alpha02:00

Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics (NASDAQ:VKTX).And retail traders should know.We noticed this today when the trades showed up on publicly avail

BenzingaJul 6 04:49

Study Links GLP-1 Drugs, Metformin to Lower Risk of Certain Cancers

Seeking AlphaJul 6 03:04

BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125

BTIG analyst Justin Zelin maintains $Viking Therapeutics(VKTX.US)$ with a buy rating, and maintains the target price at $125.According to TipRanks data, the analyst has a success rate of 37.8% and a t

Futu NewsJul 4 21:31 · Ratings

Optimistic Outlook for Viking Therapeutics' Obesity Treatments Amid Upcoming Catalysts and Regulatory Progress

TipRanksJul 4 21:15

A Harvard study shows that semaglutide is related to rare vision loss. Novo Nordisk (NVO.US) leads the weight loss drug concept stocks in decline.

A Harvard study shows that the weight loss drugs Ozempic and Wegovy from Novo Nordisk A/S may be associated with rare vision loss.

Zhitong FinanceJul 4 14:42